Regeneron Pharmaceuticals (NQ:REGN)

803.17 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Price and Volume

Volume	188
Open	803.17
Bid (Size)	799.95 (40)
Ask (Size)	802.78 (40)
Prev. Close	803.17
Today's Range	803.17 - 803.17
52wk Range	476.49 - 821.11
Shares Outstanding	91,779,465
Dividend Yield	0.44%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Sanofi Tightens Grip on Ocular Therapeutix with Revised Bid as Pivotal SOL-1 Trial Results Loom

February 16, 2026

In a move that could reshape the multi-billion-dollar retinal disease market, French pharmaceutical giant Sanofi (NASDAQ: SNY) has reportedly returned to the negotiating table with a significantly...

Via MarketMinute

Retina’s ‘Sustained’ Moment: Ocular Therapeutix Braces for Game-Changing Phase 3 AXPAXLI Data

February 16, 2026

The multi-billion dollar wet Age-Related Macular Degeneration (wet AMD) market is standing on the precipice of a transformative shift. Today, February 16, 2026, Ocular Therapeutix (NASDAQ: OCUL) is in...

Via MarketMinute

Performance

YTD	+3.5%	+3.5%
1 Month	+9.5%	+9.5%
3 Month	+14.0%	+14.0%
6 Month	+39.9%	+39.9%
1 Year	+18.1%	+18.1%

More News

1 Healthcare Stock Worth Your Attention and 2 Facing Challenges

February 12, 2026

Via StockStory

Regeneron Stock Slips Premarket Even After Wall Street Lifts Targets On Strong Q4 — What’s Weighing On The Stock? ↗

February 02, 2026

Via Stocktwits

Regeneron Pharmaceuticals (NASDAQ:REGN) Reports Q4 2025 Earnings Beat Amid Product Transition ↗

January 30, 2026

Via Chartmill

Regeneron Announces Investor Conference Presentations

February 11, 2026

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy

February 10, 2026

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

The Great Reversal: Tariffs Ignite Goods Inflation as Services Cool in Latest PCE Data

February 06, 2026

Via MarketMinute

Regeneron (REGN) Q1 2025 Earnings Call Transcript ↗

February 05, 2026

Via The Motley Fool

Regeneron (REGN) Q2 2025 Earnings Call Transcript ↗

February 05, 2026

Via The Motley Fool

Regeneron (REGN) Q4 2024 Earnings Call Transcript ↗

February 05, 2026

Via The Motley Fool

Regeneron (REGN) Q3 2024 Earnings Call Transcript ↗

February 05, 2026

Via The Motley Fool

EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases

February 02, 2026

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

This $24 Million Buy Amid a 45% Stock Drop Signals Conviction in a High-Margin Data Business ↗

January 30, 2026

Via The Motley Fool

Regeneron (REGN) Q4 2025 Earnings Call Transcript ↗

January 30, 2026

Via The Motley Fool

These S&P500 stocks that are showing activity before the opening bell on Friday. ↗

January 30, 2026

Via Chartmill

Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock ↗

January 30, 2026

Via Stocktwits

Regeneron (NASDAQ:REGN) Posts Better-Than-Expected Sales In Q4 CY2025

January 30, 2026

Via StockStory

Regeneron Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

January 30, 2026

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

Earnings To Watch: Regeneron (REGN) Reports Q4 Results Tomorrow

January 28, 2026

Via StockStory

2 Healthcare Stocks Poised for a Comeback in 2026 ↗

January 22, 2026

Via The Motley Fool

GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics

January 20, 2026

Via MarketMinute

Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗

January 19, 2026

Via MarketBeat

3 Profitable Stocks We Think Twice About

January 18, 2026

Via StockStory

1 Mooning Stock with Exciting Potential and 2 Facing Headwinds

January 12, 2026

Via StockStory

Frequently Asked Questions

Is Regeneron Pharmaceuticals publicly traded?

Yes, Regeneron Pharmaceuticals is publicly traded.

What exchange does Regeneron Pharmaceuticals trade on?

Regeneron Pharmaceuticals trades on the Nasdaq Stock Market

What is the ticker symbol for Regeneron Pharmaceuticals?

The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market

What is the current price of Regeneron Pharmaceuticals?

The current price of Regeneron Pharmaceuticals is 803.17

When was Regeneron Pharmaceuticals last traded?

The last trade of Regeneron Pharmaceuticals was at 02/13/26 04:00 PM ET

What is the market capitalization of Regeneron Pharmaceuticals?

The market capitalization of Regeneron Pharmaceuticals is 73.71B

How many shares of Regeneron Pharmaceuticals are outstanding?

Regeneron Pharmaceuticals has 74B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.